Gros David-Alexandre C
- SEC CIK
- 0001644489
No open-market purchases or sales filed in the past year.
Current role at each company
- ELDN Eledon Pharmaceuticals, Inc.Chief Executive Officeras of Aug 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gros David-Alexandre C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2021 (view filing) | Dec 20 | 1 day | Gros David-Alexandre CChief Executive Officer | PPurchase | +2.00K | $4.48 | +$8.96K | +28.6%9.00K after | |
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Gros David-Alexandre CChief Executive Officer | PPurchase | +4.00K | $6.21 | +$24.8K | +133.3%7.00K after |